Advances in Coronaviruses Research: Important Emerging Human Pathogens
A special issue of Diseases (ISSN 2079-9721). This special issue belongs to the section "Infectious Disease".
Deadline for manuscript submissions: closed (15 June 2016) | Viewed by 53207
Special Issue Editor
Special Issue Information
Dear Colleagues,
Coronaviruses have been associated with human and animal diseases for many years. Human coronaviruses OC43 (HCoV-OC43) and 229E (HCoV-229E), the two community-acquired human coronaviruses, were recognized to cause a mild, self-limited respiratory infection (common cold) in human in the middle 1960s. This list of ‘low’ pathogenic coronaviruses was recently expanded by the addition of two human coronaviruses, human coronavirus NL63 (HCoV-NL63) in 2004 and HCoV-HKU1 in 2005. With the discovery of the two highly pathogenic, zoonotic coronaviruses, the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 and the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2013, coronavirus infection is now emerging as a global public health concern.
The six human coronaviruses identified so far cause diseases with a range of clinical manifestations from mild respiratory infections to severe acute respiratory syndrome. This Special Issue provides an Open Access opportunity to publish research and review articles on human coronaviruses as emerging human pathogens. The focus will be put on a comprehensive review of current literature on viral pathogenesis, virus-host interaction and viral mechanisms to regulate host antiviral responses.
Assoc. Prof. Ding Xiang Liu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human coronaviruses
- emerging pathogens
- replication
- pathogenesis
- virus-host interactions
- anti-viral immunity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
